Vitaspring Biomedical (VSBC) EBITDA Margin (2017 - 2022)
Vitaspring Biomedical's EBITDA Margin came in at 23.28% for fiscal Q1 2023 (quarter ended Apr 30, 2022), down 17.51 percentage points from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) EBITDA Margin (2017 - 2022) Analysis & Trends
For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical's EBITDA Margin was 20.22%, up 191.61 percentage points from FY2021.
- EBITDA Margin carries a four-year change of +57.18 percentage points (FY2018 to FY2022).
- Going back by fiscal year, EBITDA Margin was -171.39% in FY2021 (-220.06 pp), 48.67% in FY2020 (+176.41 pp), -127.74% in FY2019 (-90.78 pp) and -36.96% in FY2018.
- The fiscal Q1 2023 figure represents the lowest quarterly EBITDA Margin since fiscal Q4 2021.
- The fastest year-over-year change in EBITDA Margin over five years came in fiscal Q4 2019 (a gain of 703.64 percentage points), and the weakest in fiscal Q3 2019 (a drop of 16750.41 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2022 | 23.28% |
| Jan 31, 2022 | 40.79% |
| Oct 31, 2021 | 70.61% |
| Jan 31, 2021 | -139.29% |
| Jan 31, 2020 | -138.76% |
| Apr 30, 2019 | -116.40% |
| Jan 31, 2019 | 2,621.88% |
| Oct 31, 2018 | -16,753.33% |
| Jul 31, 2018 | -592.80% |
| Apr 30, 2018 | 40.89% |
| Jan 31, 2018 | 1,918.24% |
| Oct 31, 2017 | -2.92% |
| Jul 31, 2017 | -21.12% |
| Apr 30, 2017 | 186.94% |
API Access
Vitaspring Biomedical EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();